YKL-40/CHI3L1 drives inflammation on the road of tumor progression

  • Libreros S
  • Iragavarapu-Charyulu V
88Citations
Citations of this article
86Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Inflammation plays a vital role at different stages of tumor progression. The development of tumors is affected by inflammatory mediators produced by the tumor and the host. YKL-40/chitinase-3-like-1 protein is often up-regulated in inflammation-associated diseases. With the use of chronic inflammatory disease systems, we describe the role of YKL-40/chitinase-3-like-1 protein in enhancing the inflammatory response and its implications in tumorigenesis. We also discuss how pre-existing inflammation enhances tumor growth and metastasis. In this mini-review, we highlight the effect of YKL-40/chitinase-3-like-1 protein-associated inflammation in promoting tumor progression.

Cite

CITATION STYLE

APA

Libreros, S., & Iragavarapu-Charyulu, V. (2015). YKL-40/CHI3L1 drives inflammation on the road of tumor progression. Journal of Leukocyte Biology, 98(6), 931–936. https://doi.org/10.1189/jlb.3vmr0415-142r

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free